Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine vs Morphine vs Ketamine + Morphine for Intertrochanteric Hip Fracture Pain
IRCT20230808059075N1Phase 3Completed
- Sponsor
- Lorestan University of Medical Sciences
- Start
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in intertrochanteric fracture comparing Ketamine monotherapy, Morphine sulfate monotherapy and Ketamine + morphine sulfate combination (3 arms). Primary endpoint: Pain intensity reduction. Started Aug 2023; status: completed.
02
Drugs
ketaminemorphine
03
Conditions
intertrochanteric fracture
Beyond the preview
Go deeper on IRCT20230808059075N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230808059075N1.